Section Arrow
ASND.NASDAQ
- Ascendis Pharma A/S
Quotes are at least 15-min delayed:2026/10/24 21:27 EDT
Regular Hours
Last
 243.37
+0.38 (+0.16%)
Day High 
244.58 
Prev. Close
242.99 
1-M High
243.87 
Volume 
575.68K 
Bid
225.05
Ask
255
Day Low
240.79 
Open
242 
1-M Low
219.52 
Market Cap 
15.99B 
Currency 美元 
P/E 19.35 
%Yield -- 
10-SMA 230.45 
20-SMA 228.82 
50-SMA 242.65 
52-W High 282.15 
52-W Low 188.0711 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
11.19/11.38
Enterprise Value
16.37B
Balance Sheet
Book Value Per Share
24.51
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
720.13M
Operating Revenue Per Share
2.44
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
LABTLakewood-Amedex Biotherapeutics Inc0.31-0.1795-36.67%-- 
MRNAModerna200.1-2.53-1.25%-- 
RXRXRecursion Pharmaceuticals3.7+0.12+3.35%-- 
AARDAardvark Therapeutics Inc1.39-2.56-64.81%-- 
TNGXTango Therapeutics23.34-4.59-16.43%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.